Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
The role of Glicentin in development of obesity-related type 2 diabetes
| Reference number | 2013-05207 |
| Coordinator | Uppsala universitet - Uppsala universitet Innovation |
| Funding from Vinnova | SEK 391 500 |
| Project duration | December 2013 - November 2014 |
| Status | Completed |
